CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Pentoxifylline

己酮可可碱 杂质对照品Pentoxifylline Impurities

EP39 个杂质条目39 impurity entries

本页汇总 己酮可可碱 的 39 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 39 impurity reference standards of Pentoxifylline with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 己酮可可碱(Pentoxifylline)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsDevelopment and Validation a UPLC-MS/MS Method for Quantification of Pentoxifylline in Beagle Plasma: Application for Pharmacokinetic Study of Food Effect
    Drug design, development and therapy · 2023 · Xu Y et al.  ·  PMID 38046282  ·  DOI
  2. 分析方法Analytical MethodsDegradation of pharmaceutical compound pentoxifylline in water by non-thermal plasma treatment
    Water research · 2010 · Magureanu M et al.  ·  PMID 20398913  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisPentoxifylline inhibits tumor necrosis factor-alpha induced synthesis of complement component C3 in human endothelial cells
    Biological & pharmaceutical bulletin · 2004 · Hoie EB et al.  ·  PMID 15467217  ·  DOI
  • 合成方法SynthesisPentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast-like cells
    Hepatology (Baltimore, Md.) · 1997 · Préaux AM et al.  ·  PMID 9252140  ·  DOI
  • 合成方法SynthesisInhibitory effect of pentoxifylline on HLA-DR expression and glycosaminoglycan synthesis of retrobulbar fibroblasts induced by interferon gamma
    Acta microbiologica et immunologica Hungarica · 1997 · Balázs C et al.  ·  PMID 9330666

己酮可可碱 —— 原料药与杂质对照品Pentoxifylline — drug substance & impurities

共 40 个条目(含原料药本体)40 items incl. the drug substance
Pentoxifylline structure
EP原料药 APIAPI
己酮可可碱Pentoxifylline
Pentoxifylline
CAS No.6493-05-6
Chemical FormulaC13H18N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 1 (Pentoxifylline EP Impurity A) structure
EPA
己酮可可碱杂质1 (己酮可可碱EP杂质A)Pentoxifylline Impurity 1 (Pentoxifylline EP Impurity A)
Pentoxifylline Impurity 1 (Pentoxifylline EP Impurity A)
CAS No.83-67-0
Chemical FormulaC7H8N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 4(Pentoxifylline EP Impurity D) structure
EPD
己酮可可碱杂质4(己酮可可碱EP杂质D)Pentoxifylline Impurity 4(Pentoxifylline EP Impurity D)
Pentoxifylline Impurity 4(Pentoxifylline EP Impurity D)
CAS No.59413-14-8
Chemical FormulaC10H14N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 5(Pentoxifylline EP Impurity E) structure
EPE
己酮可可碱杂质5(己酮可可碱EP杂质E)Pentoxifylline Impurity 5(Pentoxifylline EP Impurity E)
Pentoxifylline Impurity 5(Pentoxifylline EP Impurity E)
CAS No.77196-87-3
Chemical FormulaC15H16N8O4
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 7(Pentoxifylline EP Impurity G) structure
EPG
己酮可可碱杂质7(己酮可可碱EP杂质G)Pentoxifylline Impurity 7(Pentoxifylline EP Impurity G)
Pentoxifylline Impurity 7(Pentoxifylline EP Impurity G)
CAS No.93079-86-8
Chemical FormulaC13H18N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 8 Monomer (Pentoxifylline EP Impurity H) structure
EPH
己酮可可碱杂质8 单体(己酮可可碱EP杂质H)Pentoxifylline Impurity 8 Monomer (Pentoxifylline EP Impurity H)
Pentoxifylline Impurity 8 Monomer (Pentoxifylline EP Impurity H)
CAS No.200556-62-3
Chemical FormulaC18H26N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 9(Pentoxifylline EP Impurity I) structure
EPI
己酮可可碱杂质9(己酮可可碱EP杂质I)Pentoxifylline Impurity 9(Pentoxifylline EP Impurity I)
Pentoxifylline Impurity 9(Pentoxifylline EP Impurity I)
CAS No.55247-90-0
Chemical FormulaC14H14N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 10(Pentoxifylline EP Impurity J) structure
EPJ
己酮可可碱杂质10(己酮可可碱EP杂质J)Pentoxifylline Impurity 10(Pentoxifylline EP Impurity J)
Pentoxifylline Impurity 10(Pentoxifylline EP Impurity J)
CAS No.874747-30-5
Chemical FormulaC26H34N8O5
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 11(Pentoxifylline EP Impurity K) structure
EPK
己酮可可碱杂质11(己酮可可碱EP杂质K)Pentoxifylline Impurity 11(Pentoxifylline EP Impurity K)
Pentoxifylline Impurity 11(Pentoxifylline EP Impurity K)
CAS No.74857-22-0
Chemical FormulaC17H20N8O4
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 1-d6 (Pentoxifylline EP Impurity A-d6) structure
EPA-D6
己酮可可碱杂质1-d6 (己酮可可碱EP杂质A-d6)Pentoxifylline Impurity 1-d6 (Pentoxifylline EP Impurity A-d6)
Pentoxifylline Impurity 1-d6 (Pentoxifylline EP Impurity A-d6)
CAS No.117490-40-1
Chemical FormulaC7H2D6N4O2
Purity>95%询价On request
Pentoxifylline Impurity 12 structure
12
己酮可可碱杂质12Pentoxifylline Impurity 12
Pentoxifylline Impurity 12
CAS No.16015-11-5
Chemical FormulaC6H10O
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 14 structure
14
己酮可可碱杂质14Pentoxifylline Impurity 14
Pentoxifylline Impurity 14
CAS No.70486-28-1
Chemical FormulaC12H20N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 15 structure
15
己酮可可碱杂质15Pentoxifylline Impurity 15
Pentoxifylline Impurity 15
CAS No.84321-40-4
Chemical FormulaC13H20N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 16 ((+/-)-Lisofylline)-d6a structure
16
己酮可可碱杂质16(+/-利索茶碱)-d6aPentoxifylline Impurity 16 ((+/-)-Lisofylline)-d6a
Pentoxifylline Impurity 16 ((+/-)-Lisofylline)-d6a
CAS No.1185995-26-9
Chemical FormulaC13H14D6N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 16 ((+/-)-Lisofylline)-d6 structure
16
己酮可可碱杂质16(+/-利索茶碱)-d6Pentoxifylline Impurity 16 ((+/-)-Lisofylline)-d6
Pentoxifylline Impurity 16 ((+/-)-Lisofylline)-d6
CAS No.1185995-47-4
Chemical FormulaC13H14D6N4O3
Purity>95%询价On request
Pentoxifylline Impurity 16 ((+/-)-Lisofylline) structure
16
己酮可可碱杂质16(+/-利索茶碱)Pentoxifylline Impurity 16 ((+/-)-Lisofylline)
Pentoxifylline Impurity 16 ((+/-)-Lisofylline)
CAS No.6493-06-7
Chemical FormulaC13H20N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 17 structure
17
己酮可可碱杂质17Pentoxifylline Impurity 17
Pentoxifylline Impurity 17
CAS No.1243654-85-4
Chemical FormulaC13H20N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 18 structure
18
己酮可可碱杂质18Pentoxifylline Impurity 18
Pentoxifylline Impurity 18
CAS No.3744-02-3
Chemical FormulaC6H10O
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 19 structure
19
己酮可可碱杂质19Pentoxifylline Impurity 19
Pentoxifylline Impurity 19
CAS No.4160-75-2
Chemical FormulaC6H10O
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 21 structure
21
己酮可可碱杂质21Pentoxifylline Impurity 21
Pentoxifylline Impurity 21
CAS No.1597448-46-8
Chemical FormulaC7H10N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 22 structure
22
己酮可可碱杂质22Pentoxifylline Impurity 22
Pentoxifylline Impurity 22
CAS No.1597448-45-7
Chemical FormulaC8H12N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 23 structure
23
己酮可可碱杂质23Pentoxifylline Impurity 23
Pentoxifylline Impurity 23
CAS No.1410913-79-9
Chemical FormulaC13H18N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 25 structure
25
己酮可可碱杂质25Pentoxifylline Impurity 25
Pentoxifylline Impurity 25
CAS No.1329835-59-7
Chemical FormulaC18H26N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 26 structure
26
己酮可可碱杂质26Pentoxifylline Impurity 26
Pentoxifylline Impurity 26
CAS No.1329834-21-0
Chemical FormulaC18H26N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 27 structure
27
己酮可可碱杂质27Pentoxifylline Impurity 27
Pentoxifylline Impurity 27
CAS No.15837-08-8
Chemical FormulaC7H8N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 29 structure
29
己酮可可碱杂质29Pentoxifylline Impurity 29
Pentoxifylline Impurity 29
CAS No.6972-77-6
Chemical FormulaC5H7N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 30 structure
30
己酮可可碱杂质30Pentoxifylline Impurity 30
Pentoxifylline Impurity 30
CAS No.6629-04-5
Chemical FormulaC6H8N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 31 structure
31
己酮可可碱杂质31Pentoxifylline Impurity 31
Pentoxifylline Impurity 31
CAS No.55242-67-6
Chemical FormulaC12H16N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 32 structure
32
己酮可可碱杂质32Pentoxifylline Impurity 32
Pentoxifylline Impurity 32
CAS No.38975-46-1
Chemical FormulaC12H16N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 33 structure
33
己酮可可碱杂质33Pentoxifylline Impurity 33
Pentoxifylline Impurity 33
CAS No.120402-41-7
Chemical FormulaC11H16N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 34 structure
34
己酮可可碱杂质34Pentoxifylline Impurity 34
Pentoxifylline Impurity 34
CAS No.74857-33-3
Chemical FormulaC13H18N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 35 structure
35
己酮可可碱杂质35Pentoxifylline Impurity 35
Pentoxifylline Impurity 35
CAS No.1706430-15-0
Chemical FormulaC13H20N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 36 structure
36
己酮可可碱杂质36Pentoxifylline Impurity 36
Pentoxifylline Impurity 36
CAS No.1222458-45-8
Chemical FormulaC15H24N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 37 structure
37
己酮可可碱杂质37Pentoxifylline Impurity 37
Pentoxifylline Impurity 37
CAS No.13087-49-5
Chemical FormulaC7H8N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 38 structure
38
己酮可可碱杂质38Pentoxifylline Impurity 38
Pentoxifylline Impurity 38
CAS No.57987-84-5
Chemical FormulaC8H12O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 39 structure
39
己酮可可碱杂质39Pentoxifylline Impurity 39
Pentoxifylline Impurity 39
CAS No.10226-28-5
Chemical FormulaC9H14O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 40 structure
40
己酮可可碱杂质40Pentoxifylline Impurity 40
Pentoxifylline Impurity 40
CAS No.5399-21-3
Chemical FormulaC7H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 41 structure
41
己酮可可碱杂质41Pentoxifylline Impurity 41
Pentoxifylline Impurity 41
CAS No.1056638-92-6
Chemical FormulaC5H5N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 46 structure
46
己酮可可碱杂质46Pentoxifylline Impurity 46
Pentoxifylline Impurity 46
CAS No.56119-16-5
Chemical FormulaC8H10N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxifylline Impurity 47 structure
47
己酮可可碱杂质47Pentoxifylline Impurity 47
Pentoxifylline Impurity 47
CAS No.69267-75-0
Chemical FormulaC5H7BrO
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

己酮可可碱 —— 研究文献与合成路线Pentoxifylline — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 己酮可可碱 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Pentoxifylline. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Degradation studies of pentoxifylline: Isolation and characterization of a novel gem-dihydroperoxide derivative as major oxidative degradation product
    Mone MK, Chandrasekhar KB · Journal of pharmaceutical and biomedical analysis · 2010 · 被引 5cited 5
  2. Degradation kinetics and mechanism of pentoxifylline by ultraviolet activated peroxydisulfate
    Kamińska B, Majewska K, Skwierawska A, et al. · RSC advances · 2018 · 被引 2cited 2
  3. TLC determination of mebendazol and pentoxifylline as residues on pharmaceutical equipment surfaces
    Vovk I, Simonovska B · Journal of AOAC International · 2001 · 被引 3cited 3
  4. Determination of pentoxifylline in pharmaceutical formulations using iodine as oxidizing agent
    Sastry CS, Naidu PY · Talanta · 1998 · 被引 3cited 3
  5. Lack of theophylline assay interference from pentoxifylline and its metabolites
    Morton MR, Parish RC, Spruill WJ · Therapeutic drug monitoring · 1989 · 被引 1cited 1

合成路线文献Synthetic-route papers

  1. Pentoxifylline improves liver regeneration through down-regulation of TNF-α synthesis and TGF-β1 gene expression
    Martino RB, Coelho AM, Kubrusly MS, et al. · World journal of gastrointestinal surgery · 2012
  2. LPS-stimulated PMN activation and proinflammatory mediator synthesis is downregulated by phosphodiesterase inhibition: role of pentoxifylline
    Coimbra R, Loomis W, Melbostad H, et al. · The Journal of trauma · 2004
  3. Pentoxifylline inhibits the synthesis and IFN-gamma-inducing activity of IL-18
    Samardzic T, Jankovic V, Stosic-Grujicic S, et al. · Clinical and experimental immunology · 2001

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

己酮可可碱 杂质谱研究要点Pentoxifylline — impurity profiling notes

下面这些是拿到 己酮可可碱 的 40 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 40 impurity entries for Pentoxifylline, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances